⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CBIO News
Crescent Biopharma, Inc. Common Stock
Form 8-K
sec.gov
CBIO
Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC
globenewswire.com
CBIO
Continuity Biosciences erhält Fördermittel in Höhe von 9,6 Millionen US-Dollar zur Weiterentwicklung eines extrem langwirksamen Implantats zur HIV-Prävention
prnewswire.com
CBIO
Continuity Biosciences reçoit une subvention de 9,6 millions de dollars pour développer un implant à action ultra-longue pour la prévention du VIH
prnewswire.com
CBIO
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
globenewswire.com
CBIO
CaseBioscience® присоединяется к команде, получившей до $7,3 млн от ARPA-H на развитие технологий консервации и хранения клеточных лекарственных препаратов при комнатной температуре
prnewswire.com
CBIO
CaseBioscience® dołącza do zespołu, któremu ARPA-H przyznała do 7,3 mln USD na rozwój metod przechowywania produktów terapii komórkowej w temperaturze otoczenia
prnewswire.com
CBIO
CaseBioscience® se une al equipo que recibió hasta 7,3 millones de dólares de ARPA-H
prnewswire.com
CBIO
CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
prnewswire.com
CBIO